Unknown

Dataset Information

0

Antisense technology: an emerging platform for cardiovascular disease therapeutics.


ABSTRACT: Antisense oligonucleotides and small interfering RNAs, which suppress the translation of specific mRNA target proteins, are emerging as important therapeutic modalities for the treatment of cardiovascular disease. Over the last 25 years, the advances in all aspects of antisense technology, as well as a detailed understanding of the mechanism of action of antisense drugs, have enabled their use as therapeutic agents. These advancements culminated in the FDA approval of the first chronically administered cardiovascular antisense therapeutic, mipomersen, which targets hepatic apolipoprotein B mRNA. This review provides a brief history of antisense technology, highlights the progression of mipomersen from preclinical studies to multiple Phase III registration trials, and gives an update on the status of other cardiovascular antisense therapeutics currently in the clinic.

SUBMITTER: Lee RG 

PROVIDER: S-EPMC3838598 | biostudies-other | 2013 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Antisense technology: an emerging platform for cardiovascular disease therapeutics.

Lee Richard G RG   Crosby Jeff J   Baker Brenda F BF   Graham Mark J MJ   Crooke Rosanne M RM  

Journal of cardiovascular translational research 20130716 6


Antisense oligonucleotides and small interfering RNAs, which suppress the translation of specific mRNA target proteins, are emerging as important therapeutic modalities for the treatment of cardiovascular disease. Over the last 25 years, the advances in all aspects of antisense technology, as well as a detailed understanding of the mechanism of action of antisense drugs, have enabled their use as therapeutic agents. These advancements culminated in the FDA approval of the first chronically admin  ...[more]

Similar Datasets

| S-EPMC5861558 | biostudies-other
| S-EPMC8953457 | biostudies-literature
| S-EPMC9804368 | biostudies-literature
| S-EPMC5140688 | biostudies-literature
| S-EPMC8005817 | biostudies-literature
| S-EPMC8315628 | biostudies-literature
| S-EPMC9744099 | biostudies-literature
| S-EPMC10227909 | biostudies-literature
| S-EPMC3312682 | biostudies-literature
| S-EPMC6008125 | biostudies-literature